I agree that this site is using cookies. You can find further informations
here
.
X
Login
Merkliste (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
zur Desktop-Version
Toggle navigation
Merkliste
1 Ergebnisse
1
Restoring the biological activity of crizanlizumab at physi..:
Fabian Bickel
;
François Griaud
;
Wolfram Kern
...
https://www.tandfonline.com/doi/10.1080/19420862.2022.2151075. , 2023
Link:
https://doi.org/10.1080/19420862.2022.2151075
RT Journal T1
Restoring the biological activity of crizanlizumab at physiological conditions through a pH-dependent aspartic acid isomerization reaction
UL https://suche.suub.uni-bremen.de/peid=base-ftdoajarticles:oai:doaj.org_article:704ad1576cf945d7aab734d00191b085&Exemplar=1&LAN=DE A1 Fabian Bickel A1 François Griaud A1 Wolfram Kern A1 Frieder Kroener A1 Manuela Gritsch A1 Jérôme Dayer A1 Samuel Barteau A1 Blandine Denefeld A1 Chi-Ya Kao-Scharf A1 Manuel Lang A1 Izabela Slupska-Muanza A1 Carla Schmidt A1 Matthias Berg A1 Jürgen Sigg A1 Lina Boado A1 Dirk Chelius PB Taylor & Francis Group YR 2023 K1 Bioactivity reactivation K1 potency change K1 aspartate isomerization K1 succinimide K1 monoclonal antibody K1 serum K1 Therapeutics. Pharmacology K1 RM1-950 K1 Immunologic diseases. Allergy K1 RC581-607 JF https://www.tandfonline.com/doi/10.1080/19420862.2022.2151075 LK http://dx.doi.org/https://doi.org/10.1080/19420862.2022.2151075 DO https://doi.org/10.1080/19420862.2022.2151075 SF ELIB - SuUB Bremen
Export
RefWorks (nur Desktop-Version!)
Flow
(Zuerst in
Flow
einloggen, dann importieren)